Subacute Sclerosing Panencephalitis
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:abbreviation |
gptkb:SSPE
|
| gptkbp:affects |
brain
children young adults |
| gptkbp:category |
gptkb:disease
neurodegenerative disease |
| gptkbp:causedBy |
gptkb:measles_virus
|
| gptkbp:diagnosedBy |
gptkb:EEG
MRI CSF analysis |
| gptkbp:diseaseCourse |
progressive
fatal |
| gptkbp:firstDescribed |
1933
|
| https://www.w3.org/2000/01/rdf-schema#label |
Subacute Sclerosing Panencephalitis
|
| gptkbp:ICD-10_code |
A81.1
|
| gptkbp:mortalityRate |
high
|
| gptkbp:onset |
years after measles infection
|
| gptkbp:prevention |
measles vaccination
|
| gptkbp:progression |
months to years
|
| gptkbp:symptom |
gptkb:dementia
behavioral changes seizures motor dysfunction myoclonus |
| gptkbp:treatment |
antiviral drugs
immunomodulators |
| gptkbp:bfsParent |
gptkb:SSPE
|
| gptkbp:bfsLayer |
7
|